CanaQuest Medical Corp.
CANQF · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.08 | 0.03 | -0.02 |
| FCF Yield | 5.40% | -4.55% | -0.99% | -2.03% |
| EV / EBITDA | -3.88 | -4.58 | -6.45 | -3.73 |
| Quality | ||||
| ROIC | 20.36% | 30.52% | 32.08% | 96.00% |
| Gross Margin | 98.59% | 98.55% | 98.60% | -26.20% |
| Cash Conversion Ratio | -0.16 | 0.16 | 0.05 | 0.08 |
| Growth | ||||
| Revenue 3-Year CAGR | 347,066.23% | 355,016.67% | 351,627.51% | 323,409.55% |
| Free Cash Flow Growth | 148.49% | -169.33% | 59.33% | -5,703.03% |
| Safety | ||||
| Net Debt / EBITDA | -0.76 | -0.68 | -1.00 | -0.56 |
| Interest Coverage | -19.80 | -8.64 | -32.20 | -49.62 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -485,473.77 | -660,477.05 | 217.00 | 158.22 |